FDA Postpones Decision on Approving Botox for Muscle Spasticity
Irvine, California based Allergan Inc said on May 26, 2009, that FDA regulators are requiring that the company provide additional information before approving its Botox anti-wrinkle drug as a treatment for upper limb spasticity in stroke victims.
Allergan said the FDA has not requested further clinical studies, which could have delayed ...